AAPS PharmSciTech

, Volume 7, Issue 1, pp E29–E32 | Cite as

Determination of aqueous solubility by heating and equilibration: A technical note

Article

Summary and Conclusion

A modified shake-flask solubility method, where the equilibration time was shortened through heating, was used to determine the solubility of 48 different drugs and pharmaceutical excipients in pure water at room temperature. The heating process accelerates dissolution of the solid compound and frequently results in supersaturated solution. Seeding with the solid compound after heating and cooling to room temperature promotes precipitation of the solid compound in its original stable form. This modified shake-flask method generates reliable and reproducible solubility data.

Keywords

solubility solubility determination shake-flask method 

References

  1. 1.
    Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–420.CrossRefPubMedGoogle Scholar
  2. 2.
    Lipinski CA. Drug-like properties and the cause of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 2000; 44:235–249.CrossRefPubMedGoogle Scholar
  3. 3.
    Dehring KA, Workman HL, Miller KD, Mandagere A, Poole SK. Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility. J Pharm Biomed Anal. 2004;36:447–456.CrossRefPubMedGoogle Scholar
  4. 4.
    Bergström CAS, Norinder U, Luthman K, Artursson P. Experimental and computational screening models for prediction of aqueous solubility. Pharm Res. 2002;19:182–188.CrossRefPubMedGoogle Scholar
  5. 5.
    Glomme A, März J, Dressman JB. Comparison of a miniaturized shaken-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J Pharm Sci. 2005;94:1–16.CrossRefPubMedGoogle Scholar
  6. 6.
    Yalkowsky SH. Solubility and Solubilization in Aqueous Media. Washington, DC: Am Chem Soc; 1999.Google Scholar
  7. 7.
    Delaney JS. Predicting aqueous solubility from structure. Drug Discov Today. 2005;10:289–295.CrossRefPubMedGoogle Scholar
  8. 8.
    Bergström CA. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. Basic Clin Pharmacol Toxicol. 2005;96:156–161.CrossRefPubMedGoogle Scholar
  9. 9.
    Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 2005;302:18–28.CrossRefPubMedGoogle Scholar
  10. 10.
    Pitha J, Milecki J, Fales H, Pannell L, Uekama K. Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs. Int J Pharm. 1986;29:73–82.CrossRefGoogle Scholar
  11. 11.
    Rasool AA, Hussain AA, Dittert LW. Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds. J Pharm Sci. 1991;80:387–393.CrossRefPubMedGoogle Scholar
  12. 12.
    Connors KA, Amidon BL, Stella VJ. Chemical Stability of Pharmaceuticals. New York, NY: John Wiley & Sons; 1986.Google Scholar
  13. 13.
    Kabasakalian P, Britt E, Yudis MD. Solubility of some steroids in water. J Pharm Sci., 1966;55:642.CrossRefPubMedGoogle Scholar
  14. 14.
    Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. London, UK: Pharmaceutical Press; 2003.Google Scholar
  15. 15.
    Moffat AC, Osselton MD, Widdop B, eds. Clarke’s Analysis of Drugs and Poisons. 3rd ed. London, UK: Pharmaceutical Press; 2004.Google Scholar
  16. 16.
    maren TH, Conroy CW. A new class of carbonic anhydrase inhibitor. J Biol Chem. 1993;268:26233–26239.PubMedGoogle Scholar
  17. 17.
    Murphy D, Rodrídues-Cintrón F, Langevin B, Kelly RC, Rodrígues-Hornedo N. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int J Pharm. 2002;246:121–134.CrossRefPubMedGoogle Scholar
  18. 18.
    Chen X-Q, Venkatesh S. Miniature device for aqueous and non-aqueous solubility measurements during drug disovery. Pharm Res. 2004;21:1758–1761.CrossRefPubMedGoogle Scholar
  19. 19.
    Ohno K, Azuma Y, Date K, et al. Evaluation of styrene oligomers eluted from polystyrene for estrogenicity in estrogen receptor binding assay, receptor gen assay, and uterotrophic assay. Food Chem Toxicol. 2003;41:131–141.CrossRefPubMedGoogle Scholar
  20. 20.
    Jain N, Yalkowsky SE. Estimation of the aqueous solubility. I. application to organic nonelectrolytes. J Pharm Sci. 2001; 90:234–252.CrossRefPubMedGoogle Scholar
  21. 21.
    Bergström CAS, Luthman K, Artursson P. Accuracy of calculated pH-dependent aqueous drug solubility. Eur J Pharm Sci. 2004;22:387–398.CrossRefPubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2006

Authors and Affiliations

  1. 1.Faculty of PharmacyUniversity of IcelandReykjavikIceland

Personalised recommendations